News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,486 Results
Type
Article (42247)
Company Profile (253)
Press Release (664986)
Section
Business (206868)
Career Advice (2258)
Deals (35831)
Drug Delivery (96)
Drug Development (81599)
Employer Resources (177)
FDA (16405)
Job Trends (15093)
News (349544)
Policy (33015)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2646)
Accelerated approval (2)
Adcomms (21)
Allergies (78)
Alliances (50199)
ALS (83)
Alzheimer's disease (1351)
Antibody-drug conjugate (ADC) (101)
Approvals (16385)
Artificial intelligence (221)
Autoimmune disease (12)
Automation (14)
Bankruptcy (361)
Best Places to Work (11841)
BIOSECURE Act (18)
Biosimilars (96)
Biotechnology (177)
Bladder cancer (50)
Brain cancer (25)
Breast cancer (239)
Cancer (1849)
Cardiovascular disease (142)
Career advice (1884)
Career pathing (28)
CAR-T (133)
Cell therapy (382)
Cervical cancer (14)
Clinical research (65902)
Collaboration (727)
Compensation (432)
Complete response letters (18)
COVID-19 (2636)
CRISPR (34)
C-suite (191)
Cystic fibrosis (100)
Data (1778)
Decentralized trials (2)
Denatured (15)
Depression (36)
Diabetes (228)
Diagnostics (6455)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (108)
Drug pricing (96)
Drug shortages (25)
Duchenne muscular dystrophy (73)
Earnings (86759)
Editorial (32)
Employer branding (21)
Employer resources (152)
Events (112938)
Executive appointments (615)
FDA (17415)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (655)
Gene editing (92)
Generative AI (20)
Gene therapy (269)
GLP-1 (676)
Government (4447)
Grass and pollen (4)
Guidances (47)
Healthcare (19176)
Huntington's disease (23)
IgA nephropathy (20)
Immunology and inflammation (94)
Indications (24)
Infectious disease (2758)
Inflammatory bowel disease (130)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (75)
Interviews (382)
IPO (16665)
IRA (40)
Job creations (3682)
Job search strategy (1591)
Kidney cancer (9)
Labor market (30)
Layoffs (453)
Leadership (14)
Legal (8017)
Liver cancer (70)
Lung cancer (270)
Lymphoma (124)
Machine learning (2)
Management (62)
Manufacturing (256)
MASH (57)
Medical device (13640)
Medtech (13645)
Mergers & acquisitions (19603)
Metabolic disorders (600)
Multiple sclerosis (63)
NASH (17)
Neurodegenerative disease (75)
Neuropsychiatric disorders (24)
Neuroscience (1803)
NextGen: Class of 2025 (6676)
Non-profit (4553)
Northern California (2276)
Now hiring (36)
Obesity (328)
Opinion (204)
Ovarian cancer (61)
Pain (72)
Pancreatic cancer (72)
Parkinson's disease (124)
Partnered (17)
Patents (188)
Patient recruitment (86)
Peanut (45)
People (57724)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20526)
Phase II (29005)
Phase III (21625)
Pipeline (847)
Podcasts (42)
Policy (104)
Postmarket research (2588)
Preclinical (8693)
Press Release (68)
Prostate cancer (88)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (349)
Real estate (5989)
Recruiting (67)
Regulatory (22391)
Reports (43)
Research institute (2386)
Resumes & cover letters (374)
Rett syndrome (3)
RNA editing (2)
RSV (38)
Schizophrenia (61)
Series A (116)
Series B (70)
Service/supplier (12)
Sickle cell disease (49)
Southern California (1965)
Special edition (14)
Sponsored (30)
Startups (3620)
State (2)
Stomach cancer (12)
Supply chain (58)
The Weekly (26)
United States (20166)
Vaccines (656)
Venture capitalists (36)
Webinars (12)
Weight loss (223)
Women's health (31)
Worklife (14)
Date
Today (107)
Last 7 days (596)
Last 30 days (2978)
Last 365 days (34299)
2025 (6497)
2024 (35582)
2023 (40516)
2022 (51761)
2021 (56304)
2020 (54843)
2019 (47659)
2018 (35860)
2017 (32799)
2016 (32284)
2015 (38366)
2014 (31998)
2013 (27063)
2012 (29308)
2011 (30016)
2010 (27892)
Location
Africa (759)
Alabama (48)
Alaska (7)
Arizona (216)
Arkansas (12)
Asia (38537)
Australia (6327)
California (5213)
Canada (1811)
China (425)
Colorado (237)
Connecticut (252)
Delaware (121)
Europe (83853)
Florida (783)
Georgia (184)
Idaho (58)
Illinois (479)
India (22)
Indiana (283)
Iowa (7)
Japan (131)
Kansas (99)
Kentucky (24)
Louisiana (7)
Maine (60)
Maryland (804)
Massachusetts (3965)
Michigan (211)
Minnesota (359)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (63)
New Jersey (1493)
New Mexico (30)
New York (1492)
North Carolina (899)
North Dakota (8)
Northern California (2276)
Ohio (186)
Oklahoma (13)
Oregon (33)
Pennsylvania (1186)
Puerto Rico (7)
Rhode Island (24)
South America (1150)
South Carolina (16)
South Dakota (1)
Southern California (1965)
Tennessee (87)
Texas (770)
Utah (162)
Virginia (124)
Washington D.C. (56)
Washington State (500)
West Virginia (3)
Wisconsin (47)
707,486 Results for "avantor performance materials inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Avantor® Appoints Corey Walker as President of Laboratory Solutions
Avantor, Inc. announced that Corey Walker has rejoined the company as President of Avantor’s Laboratory Solutions business, reporting to CEO Michael Stubblefield.
June 21, 2024
·
4 min read
Press Releases
Avantor® Reports Fourth Quarter and Full Year 2024 Results
February 9, 2025
·
23 min read
Press Releases
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
February 4, 2025
·
4 min read
Pharm Country
Avantor® to Participate in Bernstein’s 40th Annual Strategic Decisions Conference
Avantor, Inc. announced that Michael Stubblefield , President and CEO, will be participating in a fireside chat at Bernstein’s 40th Annual Strategic Decisions Conference in New York.
May 21, 2024
·
1 min read
Press Releases
Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 3, 2025
·
1 min read
Business
Avantor® to Host Second Quarter 2024 Earnings Call on Friday, July 26, 2024
Avantor, Inc. announced that it will release its second quarter 2024 financial results before the market opens on Friday, July 26, and will hold a conference call on the same day at 8:00 a.m. Eastern Time to discuss the results.
June 28, 2024
·
1 min read
Avantor® Announces New J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease
Avantor, Inc. announced the launch of two innovative products that together sustainably optimize the gene therapy harvest process: J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease.
July 1, 2024
·
3 min read
Business
Avantor® Reports First Quarter 2024 Results
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, reported financial results for its first fiscal quarter ended March 31, 2024.
April 26, 2024
·
17 min read
Pharm Country
Avantor® to Participate in BofA Securities 2024 Health Care Conference
Avantor, Inc. announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the BofA Securities 2024 Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at approximately 10:00 a.m. Pacific Time.
May 3, 2024
·
1 min read
Press Releases
Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology
November 20, 2024
·
6 min read
1 of 70,749
Next
